Pharma Globenewswire

Merkel Cell Carcinoma Market Size in the 7MM is projected to grow by 2034, estimates DelveInsight

29 January 2026

DelveInsight’s “Merkel Cell Carcinoma Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth analysis of MCC epidemiology, market, and clinical development in MCC. In addition to this, the report provides historical and forecasted epidemiology and market data as well

Uncategorised

PD-L1 inhibitors Market Size in the 7MM was ~USD 36 Billion in 2023 and It is projected to grow by 2034, estimates DelveInsight

29 January 2026

DelveInsight’s “PD-L1 Inhibitors Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth analysis of PD-L1 inhibitors epidemiology, market, and clinical development understanding of PD-L1 inhibitors. In addition, this report provides historical and forecasted epidemiology and market data as well

Uncategorised

Focal Segmental Glomerulosclerosis Market Size (7MM) was ~USD 734 million in 2022, and It is projected to grow by 2034, estimated DelveInsight

29 January 2026

DelveInsight’s “Focal Segmental Glomerulosclerosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Focal Segmental Glomerulosclerosis, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United

Uncategorised

Vitiligo Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

29 January 2026

DelveInsight’s, “Vitiligo Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Vitiligo pipeline landscape. It covers the Vitiligo pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Vitiligo pipeline therapeutics assessment by

News

FDA Launches PreCheck Pilot Program to Accelerate U.S. Pharmaceutical Manufacturing; Applications Open February 1, 2026

27 January 2026

The U.S. Food and Drug Administration announced that it will begin accepting applications on February 1, 2026, for the FDA PreCheck Pilot Program, a transformative initiative designed to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability and accelerating the development

Market Insights

Dermatomyositis Market Poised for Strong Growth Through 2034, Reports DelveInsight

22 January 2026

According to DelveInsight’s latest report, “Dermatomyositis Market Insights, Epidemiology, and Market Forecast – 2034,” the global dermatomyositis market is expected to experience robust growth through 2034, driven by rising disease awareness, expanding diagnostic rates, and a rapidly advancing therapeutic pipeline. The report

Market Insights

Multiple Sclerosis Pipeline 2025: Clinical Progress, MOA, ROA, and Regulatory Advances

22 January 2026

Multiple Sclerosis Pipeline 2025: Clinical Progress, MOA, ROA, and Regulatory Advances – DelveInsight Las Vegas, Nevada, United States – DelveInsight has released its latest industry report, “Multiple Sclerosis Pipeline Insight, 2025,” delivering a comprehensive overview of the evolving Multiple Sclerosis (Multiple Sclerosis)

Uncategorised

Cannabinoid Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Domain | DelveInsight

22 January 2026

DelveInsight’s, “Cannabinoid Pipeline Insight, 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Cannabinoid pipeline landscape. It covers the Cannabinoid pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cannabinoid pipeline therapeutics assessment by

Uncategorised

PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to increase by 2034, estimates DelveInsight

22 January 2026

DelveInsight’s “Pulmonary Hypertension associated with Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Pulmonary Hypertension associated with Interstitial Lung Disease, historical and forecasted epidemiology, as well as the Pulmonary Hypertension associated with Interstitial Lung Disease

Latest

Merkel Cell Carcinoma Market Size in the 7MM is projected to grow by 2034, estimates DelveInsight

PD-L1 inhibitors Market Size in the 7MM was ~USD 36 Billion in 2023 and It is projected to grow by 2034, estimates DelveInsight

Focal Segmental Glomerulosclerosis Market Size (7MM) was ~USD 734 million in 2022, and It is projected to grow by 2034, estimated DelveInsight

Vitiligo Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

FDA Launches PreCheck Pilot Program to Accelerate U.S. Pharmaceutical Manufacturing; Applications Open February 1, 2026

Dermatomyositis Market Poised for Strong Growth Through 2034, Reports DelveInsight

Multiple Sclerosis Pipeline 2025: Clinical Progress, MOA, ROA, and Regulatory Advances

Cannabinoid Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Domain | DelveInsight

PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to increase by 2034, estimates DelveInsight

Recent Posts

Banner

Newsletter

Authors